LOS ANGELES, Dec. 30, 2024 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQ: KYTX). Class Period:…